New Key Statistics Module, Z-Score and F-Score
NAS:AMPH Key Ratios
| Market Cap $ M | 2,008.88 |
| Enterprise Value $ M | 2,375.72 |
| P/E(ttm) | 15.93 |
| PE Ratio without NRI | 12.93 |
| Forward PE Ratio | -- |
| Price/Book | 3.09 |
| Price/Sales | 3.38 |
| Price/Free Cash Flow | 15.03 |
| Price/Owner Earnings | 17.00 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 644.00 |
| EPS (TTM) $ | 2.58 |
| Beneish M-Score | -1.77 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 77.30 |
| y-y EBITDA Growth Rate % | 62.60 |
| EV-to-EBIT | 11.97 |
| EV-to-EBITDA | 9.89 |
| PEG | 0.17 |
| Shares Outstanding M | 48.87 |
| Net Margin (%) | 21.35 |
| Operating Margin % | 30.57 |
| Pre-tax Margin (%) | 26.59 |
| Quick Ratio | 1.70 |
| Current Ratio | 2.17 |
| ROA % (ttm) | 11.56 |
| ROE % (ttm) | 23.71 |
| ROIC % (ttm) | 20.01 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.83 |
AMPH Number of Guru Trades
AMPH Volume of Guru Trades
Gurus Latest Trades with NAS:AMPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AMPH is held by these investors
Total 2
Amphastar Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:AMPH
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers